Thrombotic Risk Factors In Primary Antiphospholipid Syndrome
- 1 July 2005
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 36 (7) , 1490-1494
- https://doi.org/10.1161/01.str.0000170645.40562.09
Abstract
Background and Purpose— Because thromboembolic events are frequently observed in primary antiphospholipid syndrome (PAPS), we assessed the risk factors for new thrombotic episodes.Keywords
This publication has 15 references indexed in Scilit:
- Anticardiolipin Antibodies and Risk of Ischemic Stroke and Transient Ischemic AttackStroke, 2004
- Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromesPlacenta, 2004
- Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic StrokeJAMA, 2004
- A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody SyndromeNew England Journal of Medicine, 2003
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- A Retrospective Review of 61 Patients With Antiphospholipid SyndromeArchives of internal medicine (1960), 1997
- Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registryThe American Journal of Medicine, 1996
- The Management of Thrombosis in the Antiphospholipid-Antibody SyndromeNew England Journal of Medicine, 1995
- Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patientsThe American Journal of Medicine, 1994
- The antiphospholipid syndrome: ten years onThe Lancet, 1993